Schizophrenia

Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia.

Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health. 2009;12(6):989-95. DOI: 10.1111/j.1524-4733.2009.00543.x. PubMed PMID: 19402852.

Anxiety disorder comorbidity in bipolar disorder, schizophrenia and schizoaffective disorder.

Young S, Pfaff D, Lewandowski KE, Ravichandran C, Cohen BM, Öngür D. Anxiety disorder comorbidity in bipolar disorder, schizophrenia and schizoaffective disorder. Psychopathology. 2013;46(3):176-85. DOI: 10.1159/000339556. PubMed PMID: 22906962.

Long-acting injectable antipsychotics: an underutilized treatment option.

Heres S. Long-acting injectable antipsychotics: an underutilized treatment option. J Clin Psychiatry. 2014;75(11):1263-5. DOI: 10.4088/JCP.14com09541. PubMed PMID: 25470087.

What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia?

Stroup TS. What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia?. J Clin Psychiatry. 2014;75(11):1261-2. DOI: 10.4088/JCP.14com09518. PubMed PMID: 25470086.

Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients.

Grüber L, Bunse T, Weidinger E, Reichard H, Müller N. Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients. J Clin Psychiatry. 2014;75(11):1266-7. DOI: 10.4088/JCP.14l09005. PubMed PMID: 25470089.

One-year treatment continuation in patients switched to paliperidone palmitate: a retrospective study.

Hamer J, Norman TR, Kanaan RAA. One-year treatment continuation in patients switched to paliperidone palmitate: a retrospective study. J Clin Psychiatry. 2014;75(11):1267-9. DOI: 10.4088/JCP.13l08866. PubMed PMID: 25470090.

CACNA1C genomewide supported psychosis genetic variation affects cortical brain white matter integrity in Chinese patients with schizophrenia.

Woon PS, Sum MY, Kuswanto CN, Yang GL, Sitoh YY, Soong TW, et al. CACNA1C genomewide supported psychosis genetic variation affects cortical brain white matter integrity in Chinese patients with schizophrenia. J Clin Psychiatry. 2014;75(11):e1284-90. DOI: 10.4088/JCP.13m08777. PubMed PMID: 25470093.

Bridging the efficacy-effectiveness gap in the antipsychotic treatment of schizophrenia: back to the basics.

Tandon R. Bridging the efficacy-effectiveness gap in the antipsychotic treatment of schizophrenia: back to the basics. J Clin Psychiatry. 2014;75(11):e1321-2. DOI: 10.4088/JCP.14com09595. PubMed PMID: 25470099.

Recognition of patients who would benefit from LAI antipsychotic treatment: how to assess adherence.

Correll CU. Recognition of patients who would benefit from LAI antipsychotic treatment: how to assess adherence. J Clin Psychiatry. 2014;75(11):e29. DOI: 10.4088/JCP.13024tx3c. PubMed PMID: 25470105.

Schizophrenia: overview and dopamine dysfunction.

Abi-Dargham A. Schizophrenia: overview and dopamine dysfunction. J Clin Psychiatry. 2014;75(11):e31. DOI: 10.4088/JCP.13078tx2c. PubMed PMID: 25470107.